Association of gastroesophageal reflux disease with the incidence of pulmonary disease
- PMID: 40772230
- PMCID: PMC12327043
- DOI: 10.3389/fcell.2025.1552126
Association of gastroesophageal reflux disease with the incidence of pulmonary disease
Abstract
Objective: Concurrent pulmonary diseases are common in patients with gastroesophageal reflux disease (GERD). However, whether GERD increase the incidence of pulmonary diseases is uncertain because of a lack of quantitative evidence. We conducted a meta-analysis to determine whether GERD was associated with the increased incidence of subsequent of pulmonary diseases.
Methods: The PubMed, Embase, Web of Science and Cochrane Library databases were searched through 12 July 2024. The primary outcomes were asthma and pneumonia, and the secondary outcomes were pulmonary fibrosis (PF), chronic obstructive pulmonary disease (COPD), lung cancer, interstitial lung disease (ILD), bronchiectasis, bronchitis, acute lung injury (ALI), pulmonary embolism, pulmonary tuberculosis (PTB) and nontuberculous mycobacterial pulmonary disease (NTMPD). Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated to investigate the associations of prior GERD with the incidence of pulmonary diseases, and subgroup analyses based on the treatment of GERD, age and source of OR were performed.
Results: A total of 45 cohort studies were included. The pooled results indicated that GERD was significantly linked to an increased incidence of asthma (OR = 1.50, P < 0.001) and pneumonia (OR = 1.53, P < 0.001), as did PF (OR = 1.43, P = 0.001), COPD (OR = 1.41, P = 0.004), lung cancer (OR = 1.51, P < 0.001), ILD (OR = 1.28, P = 0.015), bronchiectasis (OR = 1.63, P = 0.039), bronchitis (OR = 1.24, P < 0.001), ALI (OR = 2.07, P < 0.001), pulmonary embolism (OR = 1.33, P = 0.013), PTB (OR = 1.63, P = 0.015) and NTMPD (OR = 3.36, P < 0.001). Subgroup analyses stratified by age and source of OR yielded similar results. However, no significant associations between treated GERD and the incidence of asthma (OR = 1.27, P = 0.081) or lung cancer (OR = 1.01, P = 0.97) were observed.
Conclusion: The presence of GERD is associated with an increased incidence of subsequent various pulmonary diseases, but regular treatment may eliminate this effect. These findings highlight the importance of screening and management for pulmonary diseases and of standardized therapy in patients with GERD.
Clinical trial registration no: INPLASY202490013.
Keywords: asthma; gastroesophageal reflux disease; meta-analysis; pneumonia; pulmonary disease.
Copyright © 2025 Wang, Wang, Bu, Liu, Gong and Che.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures





Similar articles
-
Immunostimulants versus placebo for preventing exacerbations in adults with chronic bronchitis or chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2022 Nov 14;11(11):CD013343. doi: 10.1002/14651858.CD013343.pub2. Cochrane Database Syst Rev. 2022. PMID: 36373977 Free PMC article.
-
Computer and mobile technology interventions for self-management in chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2017 May 23;5(5):CD011425. doi: 10.1002/14651858.CD011425.pub2. Cochrane Database Syst Rev. 2017. PMID: 28535331 Free PMC article.
-
Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2017 Jun 19;6(6):CD010010. doi: 10.1002/14651858.CD010010.pub3. Cochrane Database Syst Rev. 2017. PMID: 28626902 Free PMC article.
-
Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2014 Sep 9;(9):CD010010. doi: 10.1002/14651858.CD010010.pub2. Cochrane Database Syst Rev. 2014. Update in: Cochrane Database Syst Rev. 2017 Jun 19;6:CD010010. doi: 10.1002/14651858.CD010010.pub3. PMID: 25201571 Updated.
-
Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2014 Mar 10;2014(3):CD010115. doi: 10.1002/14651858.CD010115.pub2. Cochrane Database Syst Rev. 2014. PMID: 24615270 Free PMC article.
References
-
- Ahn K., Penn R. B., Rattan S., Panettieri R. A., Jr., Voight B. F. (2023). An SS: Menmelian randomization analysis reveals a complex genetic interplay among atopic dermatitis, asthma, and gastroesophageal reflux Disease. Am. J. Respir. Crit. Care Med. 207 (2), 130–137. 10.1164/rccm.202205-0951OC - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources